Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Roskilde County Hospital Paediatr.Dept.University Hospital Holbaek,Hospital North,Region Zealand,DK Christian Hansen A/S Ferrosan A/S |
---|---|
Information provided by: | Roskilde County Hospital |
ClinicalTrials.gov Identifier: | NCT00823056 |
Probiotics has been known as a dietary supplement for a long period. Recent clinical trials indicate that probiotics might have an effect in preventing common infection diseases in children. The investigators hypothesis is: if young children in the age of 6 month to 15 mdr. has a daily intake of a suspension containing probiotics in a period of 9 months, the incidence of diarrhoea and respiratory diseases can be reduced.
Condition | Intervention | Phase |
---|---|---|
Diarrhoea Respiratory Diseases |
Dietary Supplement: probiotics |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | The Effect of Probiotics on Infections in Toddlers |
Estimated Enrollment: | 440 |
Study Start Date: | January 2009 |
Estimated Study Completion Date: | December 2011 |
Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Placebo Comparator |
Dietary Supplement: probiotics
placebo
|
2: Active Comparator |
Dietary Supplement: probiotics
0,53 ml MCT oil containing BB12 and TH4 in daily dosage in 9 months
|
Probiotics has been known as a dietary supplement for a long period. Recent clinical trials indicate that probiotics might have an effect in preventing common infection diseases in children. Our hypothesis is: if young healthy children in the age of 6 month to 15 mdr. has a daily intake of a suspension containing probiotics( BB12 and TH4) in a period of 9 months, the incidence of diarrhoea and respiratory diseases can be reduced.
Ages Eligible for Study: | 6 Months to 7 Months |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Mette L. Gyhrs, MD. | + 45 28228767 | mlgy@regionsjaelland.dk |
Contact: Henrik A. Verder, Prof., DMSci | +45 59484201 | hav@regionsjaelland.dk |
Denmark, Region Zealand | |
Paediatr. Depart., University Hospital Holbaek, University of Copenhagen | Recruiting |
Holbaek, Region Zealand, Denmark, 4300 | |
Contact: Mette L. Gyhrs, M.D. +45 28228767 mlgy@regionsjaelland.dk | |
Contact: Henrik A. Verder, M.D. , DMsci. +45 59484200 hav@regionsjaelland.dk | |
Principal Investigator: Mette L. Gyhrs, MD. |
Principal Investigator: | Mette L. Gyhrs, MD. | ph.d student |
Responsible Party: | Paediatr. Depart., Uni. Hosp. Holbaek, Region Zealand,DK, Uni. of CPH ( Ms. Mette Louise Gyhrs, MD. ) |
Study ID Numbers: | Version 2 |
Study First Received: | January 14, 2009 |
Last Updated: | March 16, 2009 |
ClinicalTrials.gov Identifier: | NCT00823056 History of Changes |
Health Authority: | Denmark: Ethics Committee |
Probiotics Infections Children |
Diarrhea Respiratory Tract Diseases Respiration Disorders |
Respiratory Tract Diseases Respiration Disorders Infection |